Effects of Liraglutide Versus Placebo on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease-Reference-Cited by-同舟云学术

Effects of Liraglutide Versus Placebo on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease

Author:

Mann Johannes F. E.¹²,Fonseca Vivian³,Mosenzon Ofri⁴,Raz Itamar⁴,Goldman Bryan⁵,Idorn Thomas⁵,von Scholten Bernt Johan⁵,Poulter Neil R.⁶,

Affiliation:

1. Kuratorium für Dialyse Kidney Center, Munich, Germany (J.F.E.M.).

2. Department of Nephrology, Friedrich Alexander University of Erlangen, Germany (J.F.E.M.).

3. Division of Endocrinology, Tulane University Health Sciences Center, School of Medicine, New Orleans, LA (V.F.).

4. Diabetes Unit, Hadassah Hebrew University Hospital, Jerusalem, Israel (O.M., I.R.).

5. Novo Nordisk A/S, Søborg, Denmark (B.G., T.I., B.J.v.S.).

6. Imperial Clinical Trials Unit, Imperial College London, UK (N.R.P.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference39 articles.

1. On the occasion of the world diabetes day 2013; diabetes education and prevention; a nephrology point of view.;Nasri H;J Renal Inj Prev,2013

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献